JPRN-UMIN000028637招募中未知
Multicenter trial for the safety of rifaximin on hepatic encephalopathy - The study of the safety of rifaximin
ara Medical University0 个研究点目标入组 150 人开始时间: 2018年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)The impossible of oral intake 2)The pharmacokinetics is changed for patient's condition 3)The necessary medicine change the pharmacokinetics of rifaximin 4)The pregnancy and lactating 5)The allergy of rifaximin 6)The outcome evaluation is difficult for patient's condition 7)Suffering hepatoma 8)The execution plan of achievement is difficult
研究者
相似试验
招募中
2 期
Prospective study on suppression of cholangitis using rifaximin after SEMS placement for distal malignant biliary obstructioJPRN-jRCTs051210173Ikezawa Kenji30
招募中
2 期
Effect of Rifaximin on gut bacterial flora post Stem Cell Transplant in patients with Acute Leukemia.CTRI/2023/07/054803ady Tata Memorial Trust
招募中
不适用
Efficacy and safety of Rifaximin for the treatment of liver cirrhosis with covert hepatic encephalopathyiver cirrhosisJPRN-UMIN000044657Wakayama Medical University40
进行中（未招募）
2 期
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 TrialJPRN-jRCT2031190137Ohkubo Hidenori12
终止
4 期
Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic EncephalopathyHepatic EncephalopathyNCT01846663Bausch Health Americas, Inc.6